May is National Cancer Research Month, and today we focus on Dr. Peter Hosein, Associate Professor of Clinical Oncology and co-leader of the Gastrointestinal Cancers Group at the Sylvester Comprehensive Cancer Center. Dr. Hosein is a clinical researcher focused on gastrointestinal cancers. He has been the principal investigator for multiple clinical trials for patients with liver and pancreatic cancers conducted at Sylvester. He has participated in studies that has led to breakthroughs such as the early trials of nab-paclitaxel (Abraxane) and olaparib (Lynparza) for pancreatic cancer. Dr. Hosein is known for providing compassionate care to patients with pancreatic cancer as part of a strong multi-disciplinary team devoted to delivering excellent care of patients with difficult cancers.